Zdrowie i gospodarka · 02/11/2017
FDA Requests Public Comment on Proposed Collection of Information for In Vivo Radiopharmaceuticals
The Food and Drug Administration is seeking public input on proposed regulations for in vivo radiopharmaceuticals used for diagnosis and monitoring, as required by the Paperwork Reduction Act of 1995.
Source: Federal Register — Food and Drug AdministrationOpen original release →